Department of Urology and Andrology Laboratory, Russian Scientific Center of Radiology and Nuclear Medicine; Moscow, Profsoyuznaya 86,
Serbia
Case Report
Use of an Inhibitor of Tyrosine Kinase as a Targeted Therapy in a Case of Inoperable RCC
Author(s): Alexander A Klimenko and Sergey A IvanovAlexander A Klimenko and Sergey A Ivanov
Renal cell carcinoma (RCC) falls within the range of 2-3% of all oncology disorders in adults. Given the pathogenic mechanisms of RCC growth and dissemination, the disease is now actively treated by means of various types of the targeted therapy. One of the medicines available and widely used is Pazopanib which affects cancer cells in the form of inhibition of tyrosine kinase receptors. This article describes a case study of Pazopanib use in the course of treatment of inoperable RCC.
.. Read More»
DOI:
10.4172/2165-7920.1000332
Journal of Clinical Case Reports received 1345 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 